These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28759752)

  • 1. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
    Pokharkar V; Patil-Gadhe A; Palla P
    Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
    Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
    J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A; Khan S; Yeole P
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies.
    Sonawane D; Pokharkar V
    AAPS PharmSciTech; 2024 Feb; 25(2):30. PubMed ID: 38316672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of artemether-loaded NLC for intranasal delivery using central composite design.
    Jain K; Sood S; Gowthamarajan K
    Drug Deliv; 2015; 22(7):940-54. PubMed ID: 24512368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.
    Devkar TB; Tekade AR; Khandelwal KR
    Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
    Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
    Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.
    Gupta S; Kesarla R; Chotai N; Misra A; Omri A
    Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study.
    Tawfeek HM; Mekkawy AI; Abdelatif AAH; Aldosari BN; Mohammed-Saeid WA; Elnaggar MG
    Pharm Dev Technol; 2024 Oct; 29(8):841-854. PubMed ID: 39264666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.
    Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J
    Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10).
    Nanjwade BK; Kadam VT; Manvi FV
    J Biomed Nanotechnol; 2013 Mar; 9(3):450-60. PubMed ID: 23621001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation.
    Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S
    J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
    Mathure D; Ranpise H; Awasthi R; Pawar A
    Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and
    Kokare C; Koli D; Gadhave D; Mote C; Khandekar G
    Pharm Dev Technol; 2020 Jan; 25(1):28-39. PubMed ID: 31441694
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.